Joan Brunet
Joan Brunet
Hereditary Cancer Program, Catalan Institute of Oncology
Verified email at iconcologia.net
Title
Cited by
Cited by
Year
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology and Prevention Biomarkers 21 (1), 134-147, 2012
4802012
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS Genet 9 (3), e1003212, 2013
2722013
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
2292015
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez
Cell proliferation 41 (1), 59-85, 2008
1932008
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ...
BMC cancer 7 (1), 80, 2007
1842007
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680, 2017
1692017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
1682017
POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and …
F Bellido, M Pineda, G Aiza, R Valdés-Mas, M Navarro, DA Puente, ...
Genetics in Medicine 18 (4), 325-332, 2016
1642016
Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ...
JNCI: Journal of the National Cancer Institute 109 (7), 2017
1422017
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population‐based study
S de Sanjosé, M Leone, V Berez, A Izquierdo, R Font, JM Brunet, T Louat, ...
International journal of cancer 106 (4), 588-593, 2003
1332003
New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis
L Valle, E Hernández-Illán, F Bellido, G Aiza, A Castillejo, MI Castillejo, ...
Human molecular genetics 23 (13), 3506-3512, 2014
1302014
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
LS Schmidt, ML Nickerson, D Angeloni, GM Glenn, MCM Walther, ...
The Journal of urology 172 (4 Part 1), 1256-1261, 2004
1242004
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
T Puig, A Vázquez-Martín, J Relat, J Pétriz, JA Menéndez, R Porta, ...
Breast cancer research and treatment 109 (3), 471-479, 2008
1092008
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes
L Feliubadaló, A Lopez-Doriga, E Castellsagué, J Del Valle, M Menéndez, ...
European Journal of Human Genetics 21 (8), 864-870, 2013
1062013
Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.
L De Andres, J Brunet, A Lopez-Pousa, J Burgués, M Vega, JM Tabernero, ...
Journal of clinical oncology 13 (6), 1493-1500, 1995
1051995
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa™)-induced changes in the expression and nucleo-cytoplasmic …
L Ferrer-Soler, A Vazquez-Martin, J Brunet, JA Menendez, R De Llorens, ...
International journal of molecular medicine 20 (1), 3-10, 2007
1032007
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
CA Maxwell, J Benítez, L Gómez-Baldó, A Osorio, N Bonifaci, ...
PLoS Biol 9 (11), e1001199, 2011
962011
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the …
C Oliveras-Ferraros, A Vazquez-Martin, E López-Bonet, B Martín-Castillo, ...
International journal of oncology 33 (6), 1165-1176, 2008
962008
Germline mutations in FAN1 cause hereditary colorectal cancer by impairing DNA repair
N Seguí, LB Mina, C Lázaro, R Sanz-Pamplona, T Pons, M Navarro, ...
Gastroenterology 149 (3), 563-566, 2015
922015
BRCA1 and acetyl‐CoA carboxylase: the metabolic syndrome of breast cancer
J Brunet, A Vazquez‐Martin, R Colomer, B Graña‐Suarez, ...
Molecular Carcinogenesis: Published in cooperation with the University of …, 2008
922008
The system can't perform the operation now. Try again later.
Articles 1–20